We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc | LSE:0R2M | London | Ordinary Share | REGENERON PHARMACEUTICALS ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 296.60 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 13.12B | 3.95B | 36.9050 | 24.39 | 96.43B |
| Date | Time | Source | Headline |
|---|---|---|---|
| 26/1/2024 | 21:07 | ALNC |  Sanofi and Regeneron celebrate Dupixent's FDA approval |
| 11/12/2023 | 19:25 | ALNC | Leading pharmaceutical firms highlight positive trial data on lymphoma |
1 Year Regeneron Pharmaceuticals Chart |
Intraday Regeneron Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
